InfuSystem Holdings (INFU) Long-Term Investments (2021 - 2026)
InfuSystem Holdings' (INFU) quarterly Long-Term Investments came in at $766000.0 in Q1 2026, down 33.51% YoY from $1.2 million in Q1 2025, and up 2.41% on a QoQ basis from $748000.0 in Q4 2025.
InfuSystem Holdings (INFU) Long-Term Investments (2021 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 6 years of Long-Term Investments data on file, last reported at $766000.0 in Q1 2026.
- Quarterly Long-Term Investments fell 33.51% year-over-year to $766000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $766000.0 (down 33.51% YoY) and the FY2025 annual result came in at $748000.0, down 49.49% from the prior year.
- Long-Term Investments rose to $766000.0 in Q1 2026, from $748000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $2.2 million in Q3 2023 to a low of $748000.0 in Q4 2025.
- A 5-year average of $1.4 million and a median of $1.5 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments soared 453.52% — and 2025, when it sank 49.49%.
- Tracing INFU's Long-Term Investments over 5 years: stood at $2.0 million in 2022, then declined by 26.62% to $1.4 million in 2023, then advanced by 2.7% to $1.5 million in 2024, then slumped by 49.49% to $748000.0 in 2025, then increased by 2.41% to $766000.0 in 2026.
- The last three Long-Term Investments figures came in at $766000.0 (Q1 2026), $748000.0 (Q4 2025), and $850000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn | 807,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 807,000.00 |
| Mar 31, 2026 | 766,000.00 |
| Dec 31, 2025 | 748,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 949,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 355,000.00 |
| Jun 30, 2021 | 52,000.00 |